SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-4 - Registration of securities, business combinations:
SEC Accession No. 0001140361-22-032239
Filing Date
2022-09-02
Accepted
2022-09-02 17:09:36
Documents
56

Document Format Files

Seq Description Document Type Size
1 S-4 ny20005172x1_s4.htm S-4 8181286
2 EXHIBIT 3.1 ny20005172x1_ex3-1.htm EX-3.1 161349
3 EXHIBIT 3.3 ny20005172x1_ex3-3.htm EX-3.3 94276
4 EXHIBIT 4.1 ny20005172x1_ex4-1.htm EX-4.1 198233
5 EXHIBIT 10.1 ny20005172x1_ex10-1.htm EX-10.1 308735
6 EXHIBIT 10.2 ny20005172x1_ex10-2.htm EX-10.2 523403
7 EXHIBIT 10.3 ny20005172x1_ex10-3.htm EX-10.3 429571
8 EXHIBIT 10.4 ny20005172x1_ex10-4.htm EX-10.4 435772
9 EXHIBIT 10.5 ny20005172x1_ex10-5.htm EX-10.5 25072
10 EXHIBIT 10.6 ny20005172x1_ex10-6.htm EX-10.6 11384
11 EXHIBIT 10.7 ny20005172x1_ex10-7.htm EX-10.7 10672
12 EXHIBIT 10.20 ny20005172x1_ex10-20.htm EX-10.20 41477
13 EXHIBIT 21.1 ny20005172x1_ex21-1.htm EX-21.1 3368
14 EXHIBIT 21.2 ny20005172x1_ex21-2.htm EX-21.2 3732
15 EXHIBIT 23.1 ny20005172x1_ex23-1.htm EX-23.1 2628
16 EXHIBIT 23.2 ny20005172x1_ex23-2.htm EX-23.2 4440
17 EXHIBIT 23.3 ny20005172x1_ex23-3.htm EX-23.3 2712
18 FILING FEES TABLE ny20005172x1_ex107.htm EX-FILING FEES 38612
19 logo_discmedicine.jpg GRAPHIC 52230
20 logo_geminitherapeutics.jpg GRAPHIC 22228
21 logo_svbsecurities.jpg GRAPHIC 33212
22 ny20005172x1_ex10-4img001.jpg GRAPHIC 37446
23 ny20005172x1_footer01.jpg GRAPHIC 54439
24 ny20005172x1_graphic01.jpg GRAPHIC 332069
25 ny20005172x1_graphic02.jpg GRAPHIC 96130
26 ny20005172x1_graphic03.jpg GRAPHIC 95800
27 ny20005172x1_graphic04.jpg GRAPHIC 115843
28 ny20005172x1_graphic05.jpg GRAPHIC 87287
29 ny20005172x1_graphic06.jpg GRAPHIC 83925
30 ny20005172x1_graphic07.jpg GRAPHIC 108754
31 ny20005172x1_graphic08.jpg GRAPHIC 97219
32 ny20005172x1_graphic09.jpg GRAPHIC 149046
33 ny20005172x1_graphic10.jpg GRAPHIC 84685
34 ny20005172x1_graphic11.jpg GRAPHIC 88483
35 ny20005172x1_graphic12.jpg GRAPHIC 125858
36 ny20005172x1_graphic13.jpg GRAPHIC 132029
37 ny20005172x1_graphic14.jpg GRAPHIC 151038
38 ny20005172x1_graphic15.jpg GRAPHIC 45633
39 ny20005172x1_graphic16.jpg GRAPHIC 103527
40 ny20005172x1_graphic17.jpg GRAPHIC 90346
41 ny20005172x1_graphic18.jpg GRAPHIC 79045
42 ny20005172x1_graphic19.jpg GRAPHIC 84602
43 ny20005172x1_graphic20.jpg GRAPHIC 193511
44 ny20005172x1_graphic21.jpg GRAPHIC 109831
45 ny20005172x1_graphic22.jpg GRAPHIC 110182
46 ny20005172x1_graphic23.jpg GRAPHIC 144712
47 ny20005172x1_graphic24.jpg GRAPHIC 166823
48 ny20005172x1_graphic25.jpg GRAPHIC 133079
49 ny20005172x1_graphic26.jpg GRAPHIC 140816
50 ny20005172x1_graphic27.jpg GRAPHIC 165219
51 ny20005172x1_graphic28.jpg GRAPHIC 118362
52 ny20005172x1_graphic29.jpg GRAPHIC 152995
53 ny20005172x1_graphic30.jpg GRAPHIC 130201
54 ny20005172x1_graphic31.jpg GRAPHIC 102706
55 ny20005172x1_graphic32.jpg GRAPHIC 130481
56 sig_svbsecuritiesllc.jpg GRAPHIC 27523
  Complete submission text file 0001140361-22-032239.txt   16224092
Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Gemini Therapeutics, Inc. /DE (Filer) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4 | Act: 33 | File No.: 333-267276 | Film No.: 221226018
SIC: 2834 Pharmaceutical Preparations